CLDF Title
Home | Contact Us | Bookmark
    HCC   HE   HRS   NASH   PBC   THROMBOCYTOPENIA  
Centers of Educational Expertise  
Live CME Events Webcasts Slide Library Abstract Library CLDF 2019 Year in Review Conference Highlights
 
Back  
 
Reuters Health Information: Liver injury linked with worse COVID-19 outcomes

Liver injury linked with worse COVID-19 outcomes

Last Updated: 2020-07-28

By Reuters Staff

NEW YORK (Reuters Health) - Liver injury is associated with an increased risk of developing severe COVID-19 and dying of the disease, according to a systematic review and meta-analysis.

Most studies have reported abnormal liver function in association with COVID-19, but it remains unclear whether those abnormalities contribute to outcomes.

Dr. Tingbo Liang of Zhejiang University School of Medicine First Affiliated Hospital, in Hangzhou, China, and colleagues used data from nine studies including a total of 2,115 patients to estimate the prognosis of COVID-19 stratified according to liver injury.

In those studies, 37.2% to 76.3% of patients had abnormal liver function, and the prevalence of liver injury ranged from 21.5% to 45.7% of COVID-19 patients, the researchers note in Gut.

The overall incidence of liver injury was 27% and was higher in older patients with COVID-19.

Patients with liver injury had significantly lower absolute lymphocyte counts and higher erythrocyte sedimentation rates (ESR) than did patients without liver injury, but there was no remarkable difference between the groups in C-reactive protein (CRP) or absolute neutrophil count.

The odds of receiving treatment with lopinavir/ritonavir were 4.15 times greater among patients with liver injury than among those without (P<0.00001).

Patients with liver injury had 2.57 times higher odds of developing severe COVID-19 (P=0.01) and 66% greater odds of mortality (P=0.03), but the length of hospital stay did not differ significantly between the groups.

Overall, 53.5% of patients with liver injury had severe COVID-19 and 23.5% of patients with liver injury died.

"Thus," the authors conclude, "special attention should be given to any liver dysfunction while treating patients with COVID-19."

Dr. Liang did not respond to a request for comments.

SOURCE: https://bit.ly/2CJuKmm Gut, online July 15, 2020.

 
 
 
 
                               
 
HEPATITIS
HBV
HCV
HDV
 
 
HCC
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HRS
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
THROMBOCYTOPENIA
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2020 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.